Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Profit After Tax (2020 - 2025)

Maxcyte (MXCT) has disclosed Profit After Tax for 6 consecutive years, with -$9.6 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 9.45% to -$9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$44.6 million through Dec 2025, down 8.71% year-over-year, with the annual reading at -$44.6 million for FY2025, 8.71% down from the prior year.
  • Profit After Tax for Q4 2025 was -$9.6 million at Maxcyte, up from -$12.4 million in the prior quarter.
  • The five-year high for Profit After Tax was -$2.7 million in Q3 2021, with the low at -$12.4 million in Q3 2025.
  • Average Profit After Tax over 5 years is -$8.3 million, with a median of -$9.5 million recorded in 2024.
  • The sharpest move saw Profit After Tax soared 42.76% in 2022, then plummeted 167.55% in 2023.
  • Over 5 years, Profit After Tax stood at -$4.9 million in 2021, then grew by 1.33% to -$4.8 million in 2022, then fell by 9.74% to -$5.3 million in 2023, then tumbled by 100.78% to -$10.6 million in 2024, then grew by 9.45% to -$9.6 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$9.6 million, -$12.4 million, and -$12.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.